AU2001295782A1 - An acyl coenzyme a carboxylase from streptomyces - Google Patents

An acyl coenzyme a carboxylase from streptomyces

Info

Publication number: AU2001295782A1
Authority: AU; Australia
Prior art keywords: nucleic acid; acid sequence; polypeptide; accb; strain
Prior art date: 2000-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001295782A

Other languages

English (en)

Inventor

Hugo Cesar Gramajo

Eduardo Jose Rodriguez

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Plant Bioscience Ltd

Original Assignee

Plant Bioscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-23

Filing date

2001-10-23

Publication date

2002-05-06

2001-10-23 Application filed by Plant Bioscience Ltd filed Critical Plant Bioscience Ltd

2002-05-06 Publication of AU2001295782A1 publication Critical patent/AU2001295782A1/en

Status Abandoned legal-status Critical Current

Links

241000187747 Streptomyces Species 0.000 title claims description 39
108010064926 acyl-CoA carboxylase Proteins 0.000 title description 39
150000007523 nucleic acids Chemical class 0.000 claims description 81
101100000438 Mus musculus Acacb gene Proteins 0.000 claims description 62
108090000765 processed proteins & peptides Proteins 0.000 claims description 56
229920001184 polypeptide Polymers 0.000 claims description 54
102000004196 processed proteins & peptides Human genes 0.000 claims description 54
241000187432 Streptomyces coelicolor Species 0.000 claims description 43
230000000694 effects Effects 0.000 claims description 43
238000000034 method Methods 0.000 claims description 43
230000014509 gene expression Effects 0.000 claims description 42
108020004707 nucleic acids Proteins 0.000 claims description 38
102000039446 nucleic acids Human genes 0.000 claims description 38
108091028043 Nucleic acid sequence Proteins 0.000 claims description 36
108010016219 Acetyl-CoA carboxylase Proteins 0.000 claims description 35
102000000452 Acetyl-CoA carboxylase Human genes 0.000 claims description 35
108010018763 Biotin carboxylase Proteins 0.000 claims description 35
238000004519 manufacturing process Methods 0.000 claims description 30
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims description 29
230000015572 biosynthetic process Effects 0.000 claims description 21
229930001119 polyketide Natural products 0.000 claims description 20
230000001965 increasing effect Effects 0.000 claims description 17
230000003115 biocidal effect Effects 0.000 claims description 16
239000013598 vector Substances 0.000 claims description 16
150000003881 polyketide derivatives Chemical class 0.000 claims description 14
239000002253 acid Substances 0.000 claims description 13
241000894007 species Species 0.000 claims description 10
230000001105 regulatory effect Effects 0.000 claims description 9
230000001939 inductive effect Effects 0.000 claims description 8
230000004071 biological effect Effects 0.000 claims description 7
238000012258 culturing Methods 0.000 claims description 7
239000003242 anti bacterial agent Substances 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 6
241000350481 Pterogyne nitens Species 0.000 claims description 5
241001446311 Streptomyces coelicolor A3(2) Species 0.000 claims description 4
239000006143 cell culture medium Substances 0.000 claims description 3
238000003786 synthesis reaction Methods 0.000 claims description 3
241000892502 Streptomyces lividans 1326 Species 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 9
241000405217 Viola <butterfly> Species 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 63
101150013885 accB gene Proteins 0.000 description 47
239000012634 fragment Substances 0.000 description 39
LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 33
LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 33
102000004190 Enzymes Human genes 0.000 description 30
108090000790 Enzymes Proteins 0.000 description 30
239000000284 extract Substances 0.000 description 29
239000000523 sample Substances 0.000 description 26
ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 24
102000004169 proteins and genes Human genes 0.000 description 24
101100135725 Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4) pccA gene Proteins 0.000 description 23
101100322107 Neisseria meningitidis serogroup B (strain MC58) accA2 gene Proteins 0.000 description 23
230000012010 growth Effects 0.000 description 23
238000002474 experimental method Methods 0.000 description 21
239000013612 plasmid Substances 0.000 description 21
101710180724 Propionyl-CoA carboxylase beta chain Proteins 0.000 description 20
239000002609 medium Substances 0.000 description 20
229930000044 secondary metabolite Natural products 0.000 description 19
108020004414 DNA Proteins 0.000 description 17
150000001413 amino acids Chemical group 0.000 description 17
210000004027 cell Anatomy 0.000 description 17
241000588724 Escherichia coli Species 0.000 description 14
230000005526 G1 to G0 transition Effects 0.000 description 13
239000000203 mixture Substances 0.000 description 13
239000000047 product Substances 0.000 description 12
239000000758 substrate Substances 0.000 description 12
238000013518 transcription Methods 0.000 description 12
230000035897 transcription Effects 0.000 description 12
230000007704 transition Effects 0.000 description 11
238000011144 upstream manufacturing Methods 0.000 description 11
102000007132 Carboxyl and Carbamoyl Transferases Human genes 0.000 description 10
108010072957 Carboxyl and Carbamoyl Transferases Proteins 0.000 description 10
108091026890 Coding region Proteins 0.000 description 10
238000007792 addition Methods 0.000 description 10
239000007788 liquid Substances 0.000 description 10
238000013507 mapping Methods 0.000 description 10
244000005700 microbiome Species 0.000 description 10
230000037361 pathway Effects 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
239000012071 phase Substances 0.000 description 9
-1 polyketide compounds Chemical class 0.000 description 9
VTIKDEXOEJDMJP-UHFFFAOYSA-N Actinorhodine Natural products CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)c(cc(O)c3C2=O)c4cc(O)c5C(=O)C6=C(C(C)OC(CC(=O)O)C6)C(=O)c5c4O VTIKDEXOEJDMJP-UHFFFAOYSA-N 0.000 description 8
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
229910052799 carbon Inorganic materials 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
150000001875 compounds Chemical class 0.000 description 8
238000010276 construction Methods 0.000 description 8
230000010354 integration Effects 0.000 description 8
238000002156 mixing Methods 0.000 description 8
230000035899 viability Effects 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
108091034117 Oligonucleotide Proteins 0.000 description 7
VTIKDEXOEJDMJP-WYUUTHIRSA-N actinorhodin Chemical compound C([C@@H](CC(O)=O)O[C@@H]1C)C(C(C2=C(O)C=3)=O)=C1C(=O)C2=C(O)C=3C(C(=C1C2=O)O)=CC(O)=C1C(=O)C1=C2[C@@H](C)O[C@H](CC(O)=O)C1 VTIKDEXOEJDMJP-WYUUTHIRSA-N 0.000 description 7
230000006870 function Effects 0.000 description 7
239000000499 gel Substances 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
230000002103 transcriptional effect Effects 0.000 description 7
238000013519 translation Methods 0.000 description 7
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
108700028369 Alleles Proteins 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
108091081024 Start codon Proteins 0.000 description 6
239000000872 buffer Substances 0.000 description 6
210000000349 chromosome Anatomy 0.000 description 6
239000000287 crude extract Substances 0.000 description 6
230000001419 dependent effect Effects 0.000 description 6
235000014113 dietary fatty acids Nutrition 0.000 description 6
239000000194 fatty acid Substances 0.000 description 6
229930195729 fatty acid Natural products 0.000 description 6
150000004665 fatty acids Chemical group 0.000 description 6
230000006698 induction Effects 0.000 description 6
238000012163 sequencing technique Methods 0.000 description 6
241000589194 Rhizobium leguminosarum Species 0.000 description 5
230000003698 anagen phase Effects 0.000 description 5
229940088710 antibiotic agent Drugs 0.000 description 5
108091006004 biotinylated proteins Proteins 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
101150036991 pccB gene Proteins 0.000 description 5
QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 5
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
241000186361 Actinobacteria <class> Species 0.000 description 4
108700039691 Genetic Promoter Regions Proteins 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
102100026665 Malonate-CoA ligase ACSF3, mitochondrial Human genes 0.000 description 4
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 4
HIYSWASSDOXZLC-UHFFFAOYSA-N Undecylprodigiosin Natural products CCCCCCCCCCCc1ccc(C=C2N=C(C=C2OC)c2ccc[nH]2)[nH]1 HIYSWASSDOXZLC-UHFFFAOYSA-N 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
101150099430 accD5 gene Proteins 0.000 description 4
238000000137 annealing Methods 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
230000002759 chromosomal effect Effects 0.000 description 4
230000021615 conjugation Effects 0.000 description 4
239000006071 cream Substances 0.000 description 4
238000009472 formulation Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
108010089734 malonyl-CoA synthetase Proteins 0.000 description 4
239000002207 metabolite Substances 0.000 description 4
239000003921 oil Substances 0.000 description 4
235000019198 oils Nutrition 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
230000028070 sporulation Effects 0.000 description 4
229930188070 thiostrepton Natural products 0.000 description 4
NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 4
229940063214 thiostrepton Drugs 0.000 description 4
NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 4
230000009466 transformation Effects 0.000 description 4
HIYSWASSDOXZLC-HKOYGPOVSA-N undecylprodigiosin Chemical compound N1C(CCCCCCCCCCC)=CC=C1\C=C\1C(OC)=CC(C=2NC=CC=2)=N/1 HIYSWASSDOXZLC-HKOYGPOVSA-N 0.000 description 4
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 3
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 3
101100256938 Streptomyces griseus sigA gene Proteins 0.000 description 3
108700009124 Transcription Initiation Site Proteins 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000027455 binding Effects 0.000 description 3
150000007942 carboxylates Chemical class 0.000 description 3
230000021523 carboxylation Effects 0.000 description 3
238000006473 carboxylation reaction Methods 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000009918 complex formation Effects 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
101150086151 hrdB gene Proteins 0.000 description 3
238000011534 incubation Methods 0.000 description 3
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
230000035772 mutation Effects 0.000 description 3
239000002674 ointment Substances 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
125000000830 polyketide group Chemical group 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000012546 transfer Methods 0.000 description 3
238000011282 treatment Methods 0.000 description 3
238000001262 western blot Methods 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
241000023308 Acca Species 0.000 description 2
102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 2
108090000489 Carboxy-Lyases Proteins 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
241000458701 Cotylorhiza erythraea Species 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
108010039731 Fatty Acid Synthases Proteins 0.000 description 2
241000233866 Fungi Species 0.000 description 2
101100135734 Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4) pccB gene Proteins 0.000 description 2
108010081805 Malonyl-CoA decarboxylase Proteins 0.000 description 2
102100029461 Malonyl-CoA decarboxylase, mitochondrial Human genes 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
108010030975 Polyketide Synthases Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241001312734 Streptomyces parvulus Species 0.000 description 2
241000187176 Streptomyces violaceoruber Species 0.000 description 2
SAQSTQBVENFSKT-UHFFFAOYSA-M TCA-sodium Chemical compound [Na+].[O-]C(=O)C(Cl)(Cl)Cl SAQSTQBVENFSKT-UHFFFAOYSA-M 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
101150046124 accA gene Proteins 0.000 description 2
101150008263 accD gene Proteins 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000008848 allosteric regulation Effects 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
108700023293 biotin carboxyl carrier Proteins 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000013065 commercial product Substances 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
238000001952 enzyme assay Methods 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
101150066555 lacZ gene Proteins 0.000 description 2
239000006210 lotion Substances 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000008520 organization Effects 0.000 description 2
KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
239000006072 paste Substances 0.000 description 2
230000035515 penetration Effects 0.000 description 2
JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
230000019525 primary metabolic process Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
239000003826 tablet Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
201000008827 tuberculosis Diseases 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
XWJBVGZSIAZDKJ-FXQIFTODSA-N 2-[3-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]propyl]propanedioic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(C(=O)O)C(O)=O)SC[C@@H]21 XWJBVGZSIAZDKJ-FXQIFTODSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
101710149790 64 kDa protein Proteins 0.000 description 1
101710122462 65 kDa protein Proteins 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
239000004358 Butane-1, 3-diol Substances 0.000 description 1
102100027668 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 Human genes 0.000 description 1
101710134395 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 Proteins 0.000 description 1
102100027667 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Human genes 0.000 description 1
101710134389 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Proteins 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108091027551 Cointegrate Proteins 0.000 description 1
238000011537 Coomassie blue staining Methods 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
101100033261 Escherichia coli (strain K12) rclA gene Proteins 0.000 description 1
241001522878 Escherichia coli B Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108091029795 Intergenic region Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000186362 Mycobacterium leprae Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101150089617 PCCA gene Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
239000007990 PIPES buffer Substances 0.000 description 1
108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 1
108030004154 Propionyl-CoA carboxylases Proteins 0.000 description 1
239000008156 Ringer's lactate solution Substances 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
241000187398 Streptomyces lividans Species 0.000 description 1
241000187180 Streptomyces sp. Species 0.000 description 1
241001655322 Streptomycetales Species 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
229930183665 actinomycin Natural products 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000008272 agar Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000003281 allosteric effect Effects 0.000 description 1
108010065885 aminoglycoside N(3')-acetyltransferase Proteins 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000002141 anti-parasite Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
229940059720 apra Drugs 0.000 description 1
XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 1
229950006334 apramycin Drugs 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
CRFNGMNYKDXRTN-CITAKDKDSA-N butyryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CRFNGMNYKDXRTN-CITAKDKDSA-N 0.000 description 1
BMLSTPRTEKLIPM-UHFFFAOYSA-I calcium;potassium;disodium;hydrogen carbonate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].OC([O-])=O BMLSTPRTEKLIPM-UHFFFAOYSA-I 0.000 description 1
ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
229940068840 d-biotin Drugs 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
101150106284 deoR gene Proteins 0.000 description 1
231100000223 dermal penetration Toxicity 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000012215 gene cloning Methods 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
238000012268 genome sequencing Methods 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
239000008309 hydrophilic cream Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
101150062334 int gene Proteins 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
238000010983 kinetics study Methods 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
LTYOQGRJFJAKNA-VFLPNFFSSA-N malonyl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-VFLPNFFSSA-N 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
PUPNJSIFIXXJCH-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide Chemical compound C1=CC(O)=CC=C1NC(=O)CN1S(=O)(=O)C2=CC=CC=C2C1=O PUPNJSIFIXXJCH-UHFFFAOYSA-N 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
239000003883 ointment base Substances 0.000 description 1
101150093139 ompT gene Proteins 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
230000027086 plasmid maintenance Effects 0.000 description 1
239000011505 plaster Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000017363 positive regulation of growth Effects 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
229930010796 primary metabolite Natural products 0.000 description 1
230000037452 priming Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
238000001814 protein method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
230000024053 secondary metabolic process Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
230000009105 vegetative growth Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AU2001295782A 2000-10-23 2001-10-23 An acyl coenzyme a carboxylase from streptomyces Abandoned AU2001295782A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA2322105		2000-10-23
CA002322105A CA2322105A1 (fr)	2000-10-23	2000-10-23	Production d'antibiotiques (ii)
PCT/GB2001/004709 WO2002034784A2 (fr)	2000-10-23	2001-10-23	Production d'antibiotique (ii)

Publications (1)

Publication Number	Publication Date
AU2001295782A1 true AU2001295782A1 (en)	2002-05-06

Family

ID=4167299

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001295782A Abandoned AU2001295782A1 (en)	2000-10-23	2001-10-23	An acyl coenzyme a carboxylase from streptomyces

Country Status (4)

Country	Link
EP (1)	EP1328551A2 (fr)
AU (1)	AU2001295782A1 (fr)
CA (1)	CA2322105A1 (fr)
WO (1)	WO2002034784A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011038364A1 (fr)	2009-09-27	2011-03-31	Opx Biotechnologies, Inc.	Procédé de production d'acide 3-hydroxypropionique et d'autres produits
CA2788045A1 (fr) *	2010-01-27	2011-08-04	Opx Biotechnologies, Inc.	Production par micro-organismes de produits chimiques de grande qualite, compositions, procedes et systemes associes
BR112015002940A2 (pt)	2012-08-10	2018-04-24	Opx Biotechnologies Inc	microorganismos e métodos para a produção de ácidos graxos e produtos derivados de ácidos graxos.
EP2976141A4 (fr)	2013-03-15	2016-10-05	Cargill Inc	Evaporation éclair pour la purification de production et la récupération
US9447438B2 (en)	2013-03-15	2016-09-20	Cargill, Incorporated	Acetyl-coA carboxylases
US11408013B2 (en)	2013-07-19	2022-08-09	Cargill, Incorporated	Microorganisms and methods for the production of fatty acids and fatty acid derived products
WO2015010103A2 (fr)	2013-07-19	2015-01-22	Opx Biotechnologies, Inc.	Micro-organismes et procédés pour la production d'acides gras et de produits dérivés d'acides gras
EP2993228B1 (fr)	2014-09-02	2019-10-09	Cargill, Incorporated	Production d'esters d'acides gras
CN110494566A (zh)	2017-02-02	2019-11-22	嘉吉公司	产生c6-c10脂肪酸衍生物的经遗传修饰的细胞
CN112410274B (zh) *	2019-08-23	2023-01-24	上海医药工业研究院	一种生产子囊霉素的基因工程菌及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5164305A (en) *	1990-01-18	1992-11-17	Cetus Oncology Corporation	Streptomyces promoter and method of use thereof
US5639949A (en) *	1990-08-20	1997-06-17	Ciba-Geigy Corporation	Genes for the synthesis of antipathogenic substances
US5622866A (en) *	1994-06-23	1997-04-22	Merck & Co., Inc.	Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces

2000
- 2000-10-23 CA CA002322105A patent/CA2322105A1/fr not_active Abandoned
2001
- 2001-10-23 AU AU2001295782A patent/AU2001295782A1/en not_active Abandoned
- 2001-10-23 WO PCT/GB2001/004709 patent/WO2002034784A2/fr not_active Ceased
- 2001-10-23 EP EP01976514A patent/EP1328551A2/fr not_active Withdrawn

Also Published As

Publication number	Publication date
WO2002034784A3 (fr)	2003-01-16
WO2002034784A2 (fr)	2002-05-02
EP1328551A2 (fr)	2003-07-23
CA2322105A1 (fr)	2002-04-23

Publication	Publication Date	Title
Chen et al.	2017	Recent progress in ergot alkaloid research
Motamedi et al.	1998	The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506
Rodrıguez et al.	2001	Role of an essential acyl coenzyme A carboxylase in the primary and secondary metabolism of Streptomyces coelicolor A3 (2)
Mo et al.	2012	Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP
Hayashi et al.	2008	Cloning of the gene cluster responsible for the biosynthesis of brasilicardin A, a unique diterpenoid
Li et al.	2009	Analysis of the indanomycin biosynthetic gene cluster from Streptomyces antibioticus NRRL 8167
CA2767491C (fr)	2018-06-05	Procede pour preparation de tacrolimus
Mosher et al.	1999	Genes specific for the biosynthesis of clavam metabolites antipodal to clavulanic acid are clustered with the gene for clavaminate synthase 1 in Streptomyces clavuligerus
AU2001295782A1 (en)	2002-05-06	An acyl coenzyme a carboxylase from streptomyces
CN114875094B (zh)	2024-07-02	提高thaxtomin发酵产量的方法
Namwat et al.	2002	Characterization of virginiamycin S biosynthetic genes from Streptomyces virginiae
CN101363022B (zh)	2012-09-26	替曲卡星a的生物合成基因簇及其应用
Pan et al.	2013	Asm8, a specific LAL-type activator of 3-amino-5-hydroxybenzoate biosynthesis in ansamitocin production
CN106754608B (zh)	2020-08-11	生产米尔贝霉素的重组链霉菌及其制备方法和应用
Park et al.	2016	Identification of the phenalamide biosynthetic gene cluster in Myxococcus stipitatus DSM 14675
Hijarrubia et al.	2001	Characterization of the lys2 gene of Acremonium chrysogenum encoding a functional α-aminoadipate activating and reducing enzyme
Gómez et al.	2011	Amino acid precursor supply in the biosynthesis of the RNA polymerase inhibitor streptolydigin by Streptomyces lydicus
Xie et al.	2019	Enhancement of himastatin bioproduction via inactivation of atypical repressors in Streptomyces hygroscopicus
KR102159415B1 (ko)	2020-09-23	Uk-2 생합성 유전자 및 그것을 사용한 uk-2 생산성을 향상시키기 위한 방법
US20030157652A1 (en)	2003-08-21	Antibiotic production (II)
Liu et al.	2022	Acquiring novel chemicals by overexpression of a transcription factor DibT in the dibenzodioxocinone biosynthetic cluster in Pestalotiopsis microspora
CA2391131C (fr)	2004-10-12	Genes et proteines pour la biosynthese de rosaramicine
JP2010523087A (ja)	2010-07-15	二次代謝物の製造方法
CN110997700A (zh)	2020-04-10	用于在杀真菌素链霉菌的基因工程菌株中增强恩拉霉素的生产的组合物和方法
AU9421998A (en)	1999-03-04	Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis